title: Sclerosing cholangitis: pediatric perspective.
abstract: Sclerosing cholangitis is a rare progressive cholestatic liver disease affecting the biliary tract. It may be associated with other diseases including autoimmune hepatitis, immunodeficiencies, cystic fibrosis, and sickle cell disease. Sclerosing cholangitis not associated with other diseases is termed "primary sclerosing cholangitis," which has a strong association with male gender, Caucasian race, and inflammatory bowel disease. Diagnosis is based on typical biochemical, radiologic, and histologic features. Medical management is directed mainly at managing complications (pruritus, cholangitis, strictures, and nutritional deficiencies). Administration of ursodeoxycholic acid results in biochemical improvement, but has not been proven to prolong transplant-free survival. Patients with autoimmune overlap respond to immunosuppression. The disease is typically progressive and evolves to biliary cirrhosis and possibly cholangiocarcinoma. Orthotopic liver transplantation remains the only life-extending alternative for patients with sclerosing cholangitis, with good long-term patient and graft survival, and recurrent graft primary sclerosing cholangitis in about 10% of children.
authors.affiliation: Department of Pediatrics, The Mount Sinai Medical Center, New York, NY, USA. nanda.kerkar@mountsinai.org
authors.forename: Nanda
authors.initials: N
authors.lastname: Kerkar
authors.forename: Tamir
authors.initials: T
authors.lastname: Miloh
mesh_terms: D000293:Adolescent; D001652:Bile Ducts / Q000473:pathology*; D002648:Child; D002675:Child, Preschool; D015209:Cholangitis, Sclerosing / Q000150:complications / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D019693:Hepatitis, Autoimmune / Q000150:complications*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D015212:Inflammatory Bowel Diseases / Q000150:complications*; D016031:Liver Transplantation / Q000379:methods* / Q000639:trends; D008297:Male; D011379:Prognosis; D012737:Sex Factors